464 related articles for article (PubMed ID: 8629887)
1. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
[TBL] [Abstract][Full Text] [Related]
2. Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney DS
J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
[TBL] [Abstract][Full Text] [Related]
3. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.
Bremner JD; Vythilingam M; Ng CK; Vermetten E; Nazeer A; Oren DA; Berman RM; Charney DS
JAMA; 2003 Jun; 289(23):3125-34. PubMed ID: 12813118
[TBL] [Abstract][Full Text] [Related]
4. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
[TBL] [Abstract][Full Text] [Related]
5. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
Humble M
Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
[TBL] [Abstract][Full Text] [Related]
6. Sertraline: a new antidepressant.
Auster R
Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine involvement in antidepressant action.
Frazer A
J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine pharmacology: profile of a dual monoamine modulator.
Karpa KD; Cavanaugh JE; Lakoski JM
CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Jones CK; Eastwood BJ; Need AB; Shannon HE
Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
[TBL] [Abstract][Full Text] [Related]
11. The role of sertraline in the management of depression.
Shelton RC
Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
Schatzberg AF
J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
[TBL] [Abstract][Full Text] [Related]
13. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
[TBL] [Abstract][Full Text] [Related]
14. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
15. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
[TBL] [Abstract][Full Text] [Related]
16. Augmentation strategies with serotonergic-noradrenergic combinations.
Nelson JC
J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
[TBL] [Abstract][Full Text] [Related]
17. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
Preskorn SH; Alderman J; Chung M; Harrison W; Messig M; Harris S
J Clin Psychopharmacol; 1994 Apr; 14(2):90-8. PubMed ID: 8195463
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
